The Host Microbe Core (HMC) will assist and support the research base, trainees, and pilot project investigators by providing specimens, reagents, training, and services to define both the microbial and host response determinants of CF diseases in organs and tissues prioritized by the NIDDK. This Core combines the resources and expertise of specialists in CF basic and clinical microbiology, airway epithelial and immune cell biology, pathology, and microscopy to provide an integrated network of services, reflecting an evolution in the field of CF disease pathogenesis to concurrently investigate the host and pathogens. Core services available to the UW CF P30 research base include: 1. Technical assistance and state-of-the-art facilities for histopathology, immunohistochemistry, in situ hybridization and localization of host and microbial targets, and digital imaging 2. Quantitative digital pathology and whole slide digital repository for pancreata and lungs from people with CF 3. Processing clinical, animal, and laboratory specimens for microbiome, proteome, metabolome, and transcriptome analyses, and for specific targets 4. Microbial culturing of CF specimens in formats representative of CF mucosal conditions for phenotypic, proteomic, genomic, and biochemical analyses 5. Access to strains of bacteria cultured from CF clinical fecal samples, including Escherichia coli and Bacteroides spp. 6. Consultation and training in methods provided by the Core and experimental design 7. Interacting closely with the Clinical and Genomics cores to provide unified services for CF researchers

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK089507-11
Application #
9982660
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2010-08-07
Project End
2025-05-31
Budget Start
2020-08-15
Budget End
2021-05-31
Support Year
11
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Seattle Children's Hospital
Department
Type
DUNS #
048682157
City
Seattle
State
WA
Country
United States
Zip Code
98105
Matamouros, Susana; Hayden, Hillary S; Hager, Kyle R et al. (2018) Adaptation of commensal proliferating Escherichia coli to the intestinal tract of young children with cystic fibrosis. Proc Natl Acad Sci U S A 115:1605-1610
Heltshe, Sonya L; Taylor-Cousar, Jennifer L (2018) Let's talk about sex: Behaviors, experience and health care utilization in young women with CF. J Cyst Fibros 17:5-6
Ding, Fengming; Oinuma, Ken-Ichi; Smalley, Nicole E et al. (2018) The Pseudomonas aeruginosa Orphan Quorum Sensing Signal Receptor QscR Regulates Global Quorum Sensing Gene Expression by Activating a Single Linked Operon. MBio 9:
Gelfond, Daniel; Heltshe, Sonya L; Skalland, Michelle et al. (2018) Pancreatic Enzyme Replacement Therapy Use in Infants With Cystic Fibrosis Diagnosed by Newborn Screening. J Pediatr Gastroenterol Nutr 66:657-663
Hobler, Mara R; Engelberg, Ruth A; Curtis, J Randall et al. (2018) Exploring Opportunities for Primary Outpatient Palliative Care for Adults with Cystic Fibrosis: A Mixed-Methods Study of Patients' Needs. J Palliat Med 21:513-521
Hull, Rebecca L; Gibson, Ronald L; McNamara, Sharon et al. (2018) Islet Interleukin-1? Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to ?-Cell Failure. Diabetes Care 41:823-830
Heltshe, S L; Khan, U; Beckett, V et al. (2018) Longitudinal development of initial, chronic and mucoid Pseudomonas aeruginosa infection in young children with cystic fibrosis. J Cyst Fibros 17:341-347
Irons, Jessica; Hodge-Hanson, Kelsey M; Downs, Diana M (2018) PA5339, a RidA Homolog, Is Required for Full Growth in Pseudomonas aeruginosa. J Bacteriol 200:
Klose, Alexander D; Paragas, Neal (2018) Automated quantification of bioluminescence images. Nat Commun 9:4262
Roch, Melanie; Varela, Maria Celeste; Taglialegna, Agustina et al. (2018) Activity of Telavancin against Staphylococcus aureus Isolates, Including Those with Decreased Susceptibility to Ceftaroline, from Cystic Fibrosis Patients. Antimicrob Agents Chemother 62:

Showing the most recent 10 out of 222 publications